A phase III study found evuzamitide PET detected early cardiac amyloidosis more often than bone scans; Bayer plans to seek FDA review.
Pan-Amyloid Radiotracer Excels At Early Cardiac Amyloidosis Detection
Browsing Category
General
122 posts
Five Minutes A Day: The Habit That Sticks When Everything Else Slips
Sixty and Me recommends choosing one five-minute daily habit and linking it to an existing routine. The article offers advice, not research findings.
Friends Of BrainHealth Grants Advance Dementia Prevention And Brain Health Research
The 2026 Friends of BrainHealth awards back six projects on dementia risk, resilience and caregiver well-being, with a seventh chosen by audience vote.
Healthy Eating Fruits And Microgreens
Environmental Nutrition outlines ways to include whole fruit and microgreens in meals, while noting that microgreens complement rather than replace vegetables.
Only One Workout Helped Older Adults Lose Fat And Keep Muscle
A six-month study of 123 older adults found HIIT reduced fat without the lean-mass decline seen with moderate exercise.
Cost Of Drugs From Canada Set To Soar For Millions Of Americans Due To Federal Rule
A U.S. customs change taking effect Oct. 22 could make personal medication shipments from Canada harder to deliver, patient advocates say.
‘Byzantine Ownership Arrangements’: Calls To Scrutinize Coding And Profit Incentives In Nursing Home Medicare Payments
MedPAC plans to examine coding, payment accuracy and patient selection in skilled nursing and home health care, with initial findings expected in fall 2027.
Could Hidden Belly Fat Tell Me About My Brain Health?
A personal DEXA scan prompted questions about visceral fat, blood pressure and dementia risk. The scan does not diagnose brain health or predict dementia.
What Causes Alzheimer’s? 4 Leading Theories, Explained
Researchers are studying amyloid, tau, inflammation and other processes to explain Alzheimer’s. Evidence supports parts of each theory, but no single cause is settled.
Popular Longevity Supplement Fails To Meet Endpoint In Parkinson’s Trial
In the 410-person NOPARK trial, nicotinamide riboside did not improve early Parkinson’s outcomes and was linked to modestly worse scores than placebo.
